Vind jouw adviseur


Degroof Petercam acted as Joint Global Coordinator in the Initial Public Offering of Onward on Euronext Brussels and Euronext Amsterdam

Onward is a medical technology company, developing and commercializing innovative therapies to enable functional recovery for people with spinal cord injury

IMAP is pleased to announce that Degroof Petercam (IMAP Belgium) acted as Joint Global Coordinator in the up to €87 million Initial Public Offering of Onward on Euronext Brussels and Euronext Amsterdam.

Onward is a medical technology company, developing and commercializing innovative therapies to enable functional recovery for people with spinal cord injury (“SCI”). The company’s innovative technology platform is based on ARCTM Therapy, a targeted, programmed electrical stimulation of the spinal cord to restore movement and other functions in people with SCI’s to ultimately improve their quality of life.

On 21 October 2021, Onward began trading on Euronext Brussels and Euronext Amsterdam after successfully closing the offering of up to €87 million. The offering was priced on 20 October 2021 and the price per share was set at €12.75, corresponding to the middle of the pricing range and a pre-money valuation of €380 million. The proceeds of the transaction will be primarily used to fund product development and R&D activities, to conduct clinical trials in the US and Europe and to build the company’s commercial capabilities to market its existing therapies.

The Degroof Petercam (IMAP Belgium) team, led by Olivier De Vos and Erik de Clippel, acted as Joint Global Coordinator for Onward. This deal further demonstrates Degroof Petercam’s expertise in both the Healthcare industry and in Equity Capital Markets, with the books already largely oversubscribed following the first bookbuilding day.

Contact
CONNECT WITH AN ADVISOR.
Middle-market M&A is a world of opportunity, and with that comes a sea of options and moving parts. Your advisor is the compass. Contact us for a no-commitment consultation with an M&A specialist, who’ll listen carefully to your concerns and give an honest, unbiased assessment on the best way forward.
Our business is your business growth
VRAGEN? 

NEEM CONTACT MET ONS Op 

CONTACT FORMULIER 

Bedankt voor je interesse in IMAP. Gebruik onderstaande formulier om ons meer te vertellen over je huidige situatie, dan zorgen wij ervoor dat de juiste M&A expert zo snel mogelijk contact met je opneemt.